Medicine & Life Sciences
Natural Killer Cells
100%
Cell Transplantation
24%
Graft vs Host Disease
23%
Interleukin-15
21%
KIR Receptors
20%
Fetal Blood
19%
Transplants
17%
Immunotherapy
17%
Transplantation
17%
T-Lymphocytes
17%
Allogeneic Cells
17%
Tissue Donors
16%
Unrelated Donors
13%
Neoplasms
12%
Interleukin-2
12%
Acute Myeloid Leukemia
12%
Bone Marrow
11%
Recurrence
10%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10%
Cytokines
9%
Regulatory T-Lymphocytes
9%
Leukemia
9%
Hematologic Neoplasms
9%
Hematopoietic Stem Cell Transplantation
9%
Cell- and Tissue-Based Therapy
8%
Cytomegalovirus
8%
Lymphocytes
8%
ALT-803
7%
Survival
7%
Therapeutics
7%
Natural Killer Cell Receptors
6%
Homologous Transplantation
6%
Ligands
6%
Autologous Transplantation
6%
Adoptive Transfer
6%
Hematopoietic Stem Cells
6%
Blood Cells
6%
Bone Marrow Transplantation
5%
Ovarian Neoplasms
5%
Stem Cell Transplantation
5%
Lymphoma
5%
Myelodysplastic Syndromes
5%
Induced Pluripotent Stem Cells
5%
Confidence Intervals
5%